✦ LIBER ✦

TGF-β may be complimentary to PSA in Chinese prostate cancer

✍ Scribed by Yuejing Yang; Tao Sun

Book ID: 106314929
Publisher: Springer
Year: 2009
Tongue: English
Weight: 275 KB
Volume: 8
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-009-0005-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSA velocity may not be of value in pros

PSA velocity may not be of value in prostate cancer detection

✍ Johnston, Derrick; Terris, Martha K 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

Time to prostate specific antigen (PSA)

Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy

✍ Thomas, Betsan M.; Smith, Christian; Evans, Jessica; Button, Michael R.; Kumar, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 193 KB

The cancer-related Runx2 protein enhance

✍ Margaretha van der Deen; Jacqueline Akech; Tao Wang; Thomas J. FitzGerald; Dario 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

## Abstract Prostate cancer cells often metastasize to bone where osteolytic lesions are formed. Runx2 is an essential transcription factor for bone formation and suppresses cell growth in normal osteoblasts but may function as an oncogenic factor in solid tumors (e.g., breast, prostate). Here, we

171 THE RISK OF BEING DIAGNOSED WITH POT

171 THE RISK OF BEING DIAGNOSED WITH POTENTIALLY INCURABLE PROSTATE CANCER IN MEN WITH PSA 1-3 NG/ML IS NOT RELATED TO THE RATIO OF FREE PSA

✍ S. Carlsson; G. Aus; J. Hugosson; H. Lilja; C.G. Pihl 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Metabolic Gaps In Bone Formation May Be

Metabolic Gaps In Bone Formation May Be A Novel Marker To Monitor The Osseous Metastasis Of Prostate Cancer

✍ Koizumi, Mitsuru; Yonese, Junji; Fukui, Iwao; Ogata, Etsuro 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 78 KB

2203 Changes in plasma transforming grow

2203 Changes in plasma transforming growth factor beta1 (TGFβ1) levels in prostate cancer patients during radiotherapy may help select patients for adjuvant hormonal treatment

✍ Feng-Ming Kong; Randy L. Jirtle; Mitchell S. Anscher 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB